| The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis (NCT02733731) | First Affiliated Hospital, Sun Yat-Sen University | 2016-02-01 |
| Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT02625480) | Kite, A Gilead Company | 2016-02-01 |
| A Single Dose PK Study of SENS-218 in Healthy Volunteers (NCT02772796) | Simbec Research | 2016-02-01 |
| A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers (NCT02678988) | Hoffmann-La Roche | 2016-02-01 |
| Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase (NCT02667223) | Pfizer | 2016-02-01 |
| Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy Subjects (NCT02683577) | Ipsen | 2016-02-01 |
| A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs (NCT03355872) | Shanghai Henlius Biotech | 2016-02-01 |
| Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer (NCT02534922) | Oncolix, Inc. | 2016-02-01 |
| Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer (NCT02581501) | Stamford Hospital | 2016-02-01 |
| Exercise, Mood and Stress Study (NCT02887027) | Boston University Charles River Campus | 2016-02-01 |
| First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders (NCT02702648) | Idorsia Pharmaceuticals Ltd. | 2016-02-01 |
| Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants (NCT02641041) | Biogen | 2016-02-01 |
| Pharmacokinetic Study of ASP1517 With Kremezin® (NCT02693613) | Astellas Pharma Inc | 2016-02-01 |
| Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL) (NCT02588092) | ADC Therapeutics S.A. | 2016-02-01 |
| Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040b (NCT02647307) | Daiichi Sankyo | 2016-02-01 |
| Phase 1 Study for Safety and Tolerability of HL036 (NCT02717208) | HanAll BioPharma Co., Ltd. | 2016-02-01 |
| Methylphenidate-Duloxetine Combinations for Cocaine Dependence (NCT02700711) | University of Kentucky | 2016-02-01 |
| Evaluation in Vivo of Dentifrice With Nanoencapsulated Fluoride (NCT03008759) | Fabio Correia Sampaio | 2016-02-01 |
| Phase 1 Study of Quizartinib (NCT02675478) | Daiichi Sankyo Co., Ltd. | 2016-02-01 |
| A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel (NCT02650505) | LEO Pharma | 2016-02-01 |
| Effect of Itraconazole on the Pharmacokinetics of BIIB074 (NCT02698267) | Biogen | 2016-02-01 |
| To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers (NCT02690727) | Rhizen Pharmaceuticals SA | 2016-02-01 |
| PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma (NCT02615730) | Yonsei University | 2016-02-01 |
| Food Effect Study of CTP-656 in Healthy Male Volunteers (NCT02680249) | Concert Pharmaceuticals | 2016-02-01 |
| Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions (NCT03097627) | Brigham and Women's Hospital | 2016-02-01 |
| Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. (NCT02424175) | Brigham and Women's Hospital | 2016-02-01 |
| In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma (NCT02811523) | University Health Network, Toronto | 2016-02-01 |
| Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors (NCT02644460) | Emory University | 2016-02-01 |
| Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects (NCT03016494) | Daewoong Pharmaceutical Co. LTD. | 2016-02-01 |
| Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers (NCT02670187) | GeneOne Life Science, Inc. | 2016-02-01 |
| Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults (NCT02725437) | Pfizer | 2016-02-01 |
| Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR (NCT02691871) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2016-02-01 |
| Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates (NCT02499744) | Gao WeiWei | 2016-02-01 |
| The Role of Computerized Training in Post-Traumatic Stress Disorder (NCT02687555) | Ruhr University of Bochum | 2016-02-01 |
| Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers (NCT02725086) | Dong-A ST Co., Ltd. | 2016-02-01 |
| A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers (NCT02920931) | Boryung Pharmaceutical Co., Ltd | 2016-02-01 |
| PK Study of T-817 in Subjects With Hepatic Impairment (NCT02693197) | FUJIFILM Toyama Chemical Co., Ltd. | 2016-02-01 |
| VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis (NCT02718430) | Vaximm GmbH | 2016-02-01 |
| Oxytocin Treatment of Opioid Dependence (NCT02548728) | University of North Carolina, Chapel Hill | 2016-02-01 |
| Influence of Bosentan on the Pharmacokinetics of Nintedanib (NCT02667704) | Boehringer Ingelheim | 2016-02-01 |
| Phase I , MTD, Pharmacokinetic, Safety/Tolerability, Efficacy of IOP Injection for MRI in Healthy Subjects (NCT02744248) | MegaPro Biomedical Co. Ltd. | 2016-02-01 |
| PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function (NCT02775955) | Pharmaceutical Project Solutions, Inc. | 2016-02-01 |
| Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study (NCT02678299) | University of Aarhus | 2016-02-01 |
| A Study of Abemaciclib in Healthy Participants (NCT02672423) | Eli Lilly and Company | 2016-02-01 |
| Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project (NCT02685553) | Universita di Verona | 2016-02-01 |
| A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma (NCT02702141) | Seagen Inc. | 2016-02-01 |
| Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234 (NCT02711462) | Pfizer | 2016-02-01 |
| Oxytocin Aging Study (NCT02069431) | University of Florida | 2016-02-01 |
| Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) (NCT02535104) | Tamir Biotechnology, Inc. | 2016-02-01 |
| Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM) (NCT02494167) | Baylor College of Medicine | 2016-02-01 |
| Itch Relieving Effect of Botox: a Study in Healthy Subjects (NCT02639052) | Temple University | 2016-02-01 |
| T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System (NCT02662348) | Yi Miao | 2016-02-01 |
| A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects (NCT02692781) | OPKO Health, Inc. | 2016-02-01 |
| Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET (NCT02631616) | Hadassah Medical Organization | 2016-02-01 |
| A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome (NCT02697240) | University of Mississippi Medical Center | 2016-02-01 |
| Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta (NCT02650973) | Coherus Oncology, Inc. | 2016-02-01 |
| Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma (NCT02426229) | Medical University of South Carolina | 2016-02-01 |
| Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects (NCT02660736) | GlaxoSmithKline | 2016-02-01 |
| Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age (NCT02879266) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-02-01 |
| A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors (NCT02743637) | SynDevRx, Inc. | 2016-02-01 |
| Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT (NCT02728700) | Stanford University | 2016-02-01 |
| Study of Potential for Interaction of Fluconazole With F901318 (NCT02730442) | F2G Ltd | 2016-02-01 |
| Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC) (NCT02702986) | Universita di Verona | 2016-02-01 |
| Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4) (NCT02585024) | University of Auckland, New Zealand | 2016-02-01 |
| A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects (NCT02675309) | Tanabe Pharma Corporation | 2016-02-01 |
| Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients (NCT02854683) | New York Medical College | 2016-02-01 |
| Administration of Donor MultiTAA-Specific T Cells for ALL (NCT02475707) | Baylor College of Medicine | 2016-02-01 |
| A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers (NCT02685774) | Chong Kun Dang Pharmaceutical | 2016-02-01 |
| Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease. (NCT02678741) | Elios Therapeutics, LLC | 2016-02-01 |
| Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation (NCT02710188) | Nxera Pharma UK Limited | 2016-02-01 |
| Bioequivalence Study of Daclatasvir From Daclatasvir Zeta 60 mg Film Coated Tablets (Zeta Pharm Pharmaceutical Industries, Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK) (NCT02756936) | Genuine Research Center, Egypt | 2016-02-01 |
| D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) (NCT02651441) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2016-02-01 |
| Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS (NCT02706899) | Seagen Inc. | 2016-02-01 |
| Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer (NCT02690948) | Anne Chang | 2016-02-01 |
| Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure (NCT02857010) | Pere Gines | 2016-02-01 |
| Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study (NCT02697383) | Memorial Sloan Kettering Cancer Center | 2016-02-01 |
| Bioavailability Study Of PF-06651600 In Healthy Subjects (NCT02684760) | Pfizer | 2016-02-01 |
| Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia (NCT02685852) | University of Minnesota | 2016-02-01 |
| Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML (NCT02626338) | Arog Pharmaceuticals, Inc. | 2016-02-01 |
| Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases (NCT02688686) | Affiliated Hospital to Academy of Military Medical Sciences | 2016-02-01 |
| Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2 (NCT02700854) | Semmelweis University | 2016-02-01 |
| Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma (NCT02575222) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-02-01 |
| Use of F-652 in Patients With Alcoholic Hepatitis (NCT02655510) | Mayo Clinic | 2016-02-01 |
| A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors (NCT02292732) | GlaxoSmithKline | 2016-02-01 |
| Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT02588612) | GlaxoSmithKline | 2016-02-01 |
| Cockroach Nasal Allergen Challenge Pilot (NCT02710136) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-02-01 |
| NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study (NCT02692157) | New York State Psychiatric Institute | 2016-02-01 |
| Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI) (NCT03033277) | Chinese Academy of Sciences | 2016-02-01 |
| A Study of Lanabecestat (LY3314814) in Healthy Participants (NCT02663128) | AstraZeneca | 2016-01-31 |
| Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination (NCT02684799) | Tobira Therapeutics, Inc. | 2016-01-31 |
| Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin (NCT02685462) | Tobira Therapeutics, Inc. | 2016-01-31 |
| Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers (NCT03021642) | Merck KGaA, Darmstadt, Germany | 2016-01-31 |
| Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver (NCT02110953) | Fox Chase Cancer Center | 2016-01-29 |
| Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I (NCT02553460) | St. Jude Children's Research Hospital | 2016-01-29 |
| Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase (NCT02640755) | AstraZeneca | 2016-01-28 |
| A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors (NCT02663518) | Pfizer | 2016-01-28 |
| NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers (NCT02721056) | Nanobiotix | 2016-01-28 |
| A Study to Evaluate the Effect of an Acidic Formulation of Acalabrutinib (ACP-196), Acidic Beverage, or Grapefruit Juice on the Pharmacokinetics (PK) of ACP-196 Alone and Coadministered With Omeprazole (NCT04876807) | Acerta Pharma BV | 2016-01-28 |
| IDH1 Peptide Vaccine for Recurrent Grade II Glioma (NCT02193347) | Katy Peters, MD, PhD | 2016-01-28 |
| A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy Subjects (NCT02666053) | ViiV Healthcare | 2016-01-27 |